During Wednesday’s 11:15 a.m. – 12:15 p.m. panel, Foley Nanotechnology Partner and co-chair of the Life Sciences Industry Team, David Rosen, will present: Policy and Guidance Developments for FDA.
Additional panelists include:
The Federal Roundtable is expected to draw business leaders, investors, venture capitalists, scientists, engineers, government officials and visionaries who are driving the success of nanotechnology. The full day agenda will stimulate dialogue between NanoBusiness Alliance Members and Federal Agencies, explore the latest on regulatory policy/impending regulatory actions and federal research initiatives, and familiarize guests with federal product approval authorities, processes, and innovation strategies, with an emphasis on pending developments.
For more information on the Federal Roundtable agenda or the full 9th Annual Washington D.C. Roundtable event, please visit the NanoBusiness Alliance site.
